NuGen Medical Devices Inc (NGMD) - Total Liabilities
Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) has total liabilities worth CA$18.85 Million CAD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NuGen Medical Devices Inc - Total Liabilities Trend (2020–2024)
This chart illustrates how NuGen Medical Devices Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
NuGen Medical Devices Inc Competitors by Total Liabilities
The table below lists competitors of NuGen Medical Devices Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Devernois SA
PA:ALDEV
|
France | €17.06 Million |
|
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
|
USA | $152.78 Million |
|
Gore Street Energy Storage Fund Plc
LSE:GSF
|
UK | GBX666.94K |
|
St James Gold Corp
V:LORD
|
Canada | CA$3.06 Million |
|
New Zealand Coastal Seafoods Ltd
AU:NZS
|
Australia | AU$2.94 Million |
|
Electromagnetic Geoservices ASA
OL:EMGS
|
Norway | Nkr28.59 Million |
|
TVD Holdings PCL
BK:TVDH
|
Thailand | ฿626.42 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down NuGen Medical Devices Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NuGen Medical Devices Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NuGen Medical Devices Inc (2020–2024)
The table below shows the annual total liabilities of NuGen Medical Devices Inc from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$18.57 Million | +106.15% |
| 2023-12-31 | CA$9.01 Million | -1.16% |
| 2022-12-31 | CA$9.11 Million | +26.78% |
| 2021-12-31 | CA$7.19 Million | -52.88% |
| 2020-12-31 | CA$15.25 Million | -- |
About NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also pro… Read more